Body composition analyses from clinical studies reveal that weight loss with tirzepatide consists predominantly of fat mass reduction, with relative preservation of lean body mass compared to the proportion typically lost with diet-induced weight loss alone
However, it is noteworthy that a considerable number of our clients have experienced weight loss of up to 10% of their body weight within a three-month timeframe
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (under the brand name Mounjaro) and chronic weight management (under the brand name Zepbound)
Ultimately, the choice between an injection and a pill depends on your unique health needs, preferences, and lifestyle
Transcription factor MEF2C influences neural stem/progenitor cell differentiation and maturation in vivo
Higher Akkermansia levels correlate with better metabolic health markers, stronger gut barrier function, and improved insulin sensitivity
